Matches in SemOpenAlex for { <https://semopenalex.org/work/W1993655985> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W1993655985 abstract "In 1980, second-look laparotomy was introduced simultaneously into the treatment regimen for ovarian carcinoma at the two main referral centers of northern Spain. First-line chemotherapy after initial surgery was, however, different at both hospitals. At one of them (Bilbao), a combination involving the use of cisplatin was employed (cyclophosphamide 600 mg/m2, Adriamycin 45 mg/m2, and cisplatin 80 mg/m2 i.v. on day 1), whereas the patients of the other hospital were treated mainly with single-agent chemotherapy (melphalan 0.2 mg/kg p.o. on days 1-5) and never with a cisplatin combination as first-line therapy in any case. In all, 92 patients (42 stage I, 14 stage II, 33 stage III, and 3 stage IV) could be treated during the study period with optimal surgery (complete tumor excision or largest residual tumor less than 2 cm in diameter). This was followed by adjuvant chemotherapy for 12-18 months in all cases, except for 18 patients with a stage Ia borderline or G1 tumor. The latter were merely kept under observation until their second-look laparotomy after 1 year of negative follow-up. All of the 74 patients who received adjuvant chemotherapy, of whom 36 with cisplatin and 38 without, were clinically disease free after at least twelve courses of treatment and had a second-look laparotomy performed. This was positive in 33.3% of the cases after cisplatin-containing therapy and in 26.3% of the cases after cisplatin-free therapy. This difference is not statistically significant. The mean follow-up period after negative second-look was 34 months. The long-term results of both patient groups were comparable as far as rate of positive second-look laparotomies and survival rate, overall and stage for stage are concerned. The use of cisplatin did not result in any significant therapeutic improvement. It was uniformly bad tolerated by the patients and carried higher cost, since all patients had to be hospitalized for treatment." @default.
- W1993655985 created "2016-06-24" @default.
- W1993655985 creator A5033002584 @default.
- W1993655985 creator A5036468927 @default.
- W1993655985 creator A5038994636 @default.
- W1993655985 creator A5052668394 @default.
- W1993655985 creator A5072139525 @default.
- W1993655985 date "1990-01-01" @default.
- W1993655985 modified "2023-09-26" @default.
- W1993655985 title "Cisplatin-Containing versus Cisplatin-Free Adjuvant Chemotherapy in Ovarian Carcinoma" @default.
- W1993655985 doi "https://doi.org/10.1159/000226799" @default.
- W1993655985 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2314822" @default.
- W1993655985 hasPublicationYear "1990" @default.
- W1993655985 type Work @default.
- W1993655985 sameAs 1993655985 @default.
- W1993655985 citedByCount "1" @default.
- W1993655985 crossrefType "journal-article" @default.
- W1993655985 hasAuthorship W1993655985A5033002584 @default.
- W1993655985 hasAuthorship W1993655985A5036468927 @default.
- W1993655985 hasAuthorship W1993655985A5038994636 @default.
- W1993655985 hasAuthorship W1993655985A5052668394 @default.
- W1993655985 hasAuthorship W1993655985A5072139525 @default.
- W1993655985 hasConcept C121608353 @default.
- W1993655985 hasConcept C126322002 @default.
- W1993655985 hasConcept C141071460 @default.
- W1993655985 hasConcept C146357865 @default.
- W1993655985 hasConcept C151730666 @default.
- W1993655985 hasConcept C2776694085 @default.
- W1993655985 hasConcept C2776755627 @default.
- W1993655985 hasConcept C2778239845 @default.
- W1993655985 hasConcept C2778684742 @default.
- W1993655985 hasConcept C2780427987 @default.
- W1993655985 hasConcept C2780778865 @default.
- W1993655985 hasConcept C2781413609 @default.
- W1993655985 hasConcept C3019054536 @default.
- W1993655985 hasConcept C71924100 @default.
- W1993655985 hasConcept C86803240 @default.
- W1993655985 hasConcept C90924648 @default.
- W1993655985 hasConceptScore W1993655985C121608353 @default.
- W1993655985 hasConceptScore W1993655985C126322002 @default.
- W1993655985 hasConceptScore W1993655985C141071460 @default.
- W1993655985 hasConceptScore W1993655985C146357865 @default.
- W1993655985 hasConceptScore W1993655985C151730666 @default.
- W1993655985 hasConceptScore W1993655985C2776694085 @default.
- W1993655985 hasConceptScore W1993655985C2776755627 @default.
- W1993655985 hasConceptScore W1993655985C2778239845 @default.
- W1993655985 hasConceptScore W1993655985C2778684742 @default.
- W1993655985 hasConceptScore W1993655985C2780427987 @default.
- W1993655985 hasConceptScore W1993655985C2780778865 @default.
- W1993655985 hasConceptScore W1993655985C2781413609 @default.
- W1993655985 hasConceptScore W1993655985C3019054536 @default.
- W1993655985 hasConceptScore W1993655985C71924100 @default.
- W1993655985 hasConceptScore W1993655985C86803240 @default.
- W1993655985 hasConceptScore W1993655985C90924648 @default.
- W1993655985 hasLocation W19936559851 @default.
- W1993655985 hasLocation W19936559852 @default.
- W1993655985 hasOpenAccess W1993655985 @default.
- W1993655985 hasPrimaryLocation W19936559851 @default.
- W1993655985 hasRelatedWork W1975686401 @default.
- W1993655985 hasRelatedWork W1977413886 @default.
- W1993655985 hasRelatedWork W2068366515 @default.
- W1993655985 hasRelatedWork W2113780324 @default.
- W1993655985 hasRelatedWork W2126793035 @default.
- W1993655985 hasRelatedWork W2132261997 @default.
- W1993655985 hasRelatedWork W2174563169 @default.
- W1993655985 hasRelatedWork W2337014572 @default.
- W1993655985 hasRelatedWork W2419219617 @default.
- W1993655985 hasRelatedWork W2435413466 @default.
- W1993655985 isParatext "false" @default.
- W1993655985 isRetracted "false" @default.
- W1993655985 magId "1993655985" @default.
- W1993655985 workType "article" @default.